Normunity is a Biotech company based in Boston. It has raised $65M in total funding. Latest round: Series A.
Normunity funding overview
Normunity is a Biotech company based in Boston. Normunity has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Normunity runs through 2022; nothing later has been disclosed. Investors on record include Canaan Ventures, Sanofi Ventures, Taiho Ventures, Osage University Partners. 4 distinct backers are named across the disclosed rounds.
Normunity at a glance
Total raised
$65M
Latest round
Series A
Latest round date
October 2022
Industry
Biotech
Headquarters
Boston
Notable investors
Canaan Ventures, Sanofi Ventures, Taiho Ventures, Osage University Partners
Frequently asked about Normunity funding
How much has Normunity raised?
Normunity has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Normunity?
Canaan Ventures, Sanofi Ventures, Taiho Ventures, Osage University Partners are named among the investors backing Normunity.
What was the latest Normunity funding round?
The most recent disclosed round is a Series A, announced in October 2022.
Where is Normunity based?
Normunity is based in Boston.
What sector does Normunity operate in?
Normunity is tracked under Biotech from Boston, with $65M in disclosed funding.
When did Normunity last raise?
The last disclosed Normunity round closed in October 2022 at Series A.
Totals shown for Normunity aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
